The following study was conducted by Scientists from AcumenIST, Brussels, Belgium; Sandra Day O’Connor College of Law, Arizona State University, Phoenix, AZ, USA. Study is published in Nature Communications Journal as detailed below.
Nature Nanotechnology; Volume 16, Pages 362–364 (2021)
COVID-19 May Become Nanomedicine’s Finest Hour Yet
The nanotechnology-enabled mRNA-based vaccine platform recently approved against COVID-19 bears hope for improved vaccine development and trialling capacities in low- and middle-income countries as part of a broader global public health agenda.
Source:
Nature Communications
URL: https://www.nature.com/articles/s41565-021-00901-8
Citation:
Friedrichs, S., Bowman, D.M. COVID-19 may become nanomedicine’s finest hour yet. Nat. Nanotechnol. 16, 362–364 (2021). https://doi.org/10.1038/s41565-021-00901-8
